infecti
diseas
remain
lead
caus
morbid
mortal
human
rapid
accur
identif
aetiolog
agent
old
emerg
pathogen
influenc
prognosi
enabl
appropri
intervent
drug
treatment
promptli
initi
current
method
pathogen
identif
possess
number
advantag
shortcom
respect
clinic
util
exampl
nucleic
acid
detect
quantit
pcr
qpcr
extrem
rapid
sensit
provid
simultan
result
limit
number
primer
genom
region
contrast
tradit
phenotyp
method
often
limit
lengthi
incub
period
allow
identif
multipl
pathogen
current
consid
gold
standard
clinic
microbiolog
laboratori
disadvantag
nucleic
method
need
hypothesi
guid
test
requir
dna
amplif
set
primer
design
amplifi
desir
nucleic
acid
specimen
thu
case
clear
suspect
test
serial
method
qpcr
becom
oner
addit
hypothesi
wrong
neg
result
uninform
end
spectrum
method
complet
unbias
identif
organ
de
novo
genom
sequenc
slow
costli
resourc
intens
therefor
amen
clinic
set
sought
devis
protocol
maxim
advantag
approach
minim
less
desir
characterist
describ
gener
highli
parallel
method
rapidli
identifi
multipl
pathogen
genet
element
unbias
manner
without
need
specif
hypothesi
recent
dna
microarray
use
simultan
detect
identif
numer
pathogen
use
amplif
method
bryant
et
al
sever
assay
develop
employ
track
identifi
multipl
pathogen
microorgan
bacteria
gingera
et
al
troesch
et
al
wilson
et
al
vora
et
al
davignon
et
al
includ
potenti
biowarfar
agent
bacillu
anthraci
zwick
et
al
respiratori
pathogen
clinic
sampl
lin
et
al
miscellan
virus
wang
et
al
wong
et
al
palacio
et
al
howev
none
method
provid
comprehens
inform
pathogen
singl
nucleotid
level
consequ
devis
diagnost
protocol
employ
resequenc
technolog
describ
fodor
et
al
peas
et
al
chee
et
al
hacia
cutler
et
al
warrington
et
al
meet
follow
requir
unbias
requir
prior
inform
univers
highli
specif
abl
discrimin
pathogen
impart
similar
overlap
symptom
addit
approach
comprehens
sensit
influenc
human
dna
case
detect
agent
nation
institut
allergi
infecti
diseas
niaid
categori
b
c
prioriti
pathogen
list
rapid
turnaround
also
import
ideal
result
gener
day
base
refer
sequenc
resequenc
microarray
incorpor
eight
featur
consist
oligonucleotid
centr
base
four
equal
refer
c
g
centr
four
equal
revers
complement
c
g
centr
analys
intens
multipl
featur
permit
detect
refer
sequenc
well
character
rel
snp
result
indic
resequenc
microarray
capabl
accur
identif
character
pathogen
without
need
pcr
amplif
rapid
comprehens
assay
provid
clinic
relev
inform
use
acceler
treatment
decis
ultim
improv
medic
care
patient
bacteri
viral
infect
studi
three
separ
complex
mixtur
pathogen
confer
overlap
clinic
symptom
might
pose
challeng
diagnosi
first
mixtur
includ
dna
pathogen
associ
respiratori
syndrom
second
dna
pathogen
associ
mening
enceph
third
dna
organ
associ
septicaemia
three
mixtur
contain
background
human
dna
mimic
clinic
specimen
dna
prepar
nasal
wash
respiratori
mixtur
cerebrospin
fluid
csf
mixtur
human
cell
line
hela
septicaemia
mixtur
mixtur
test
array
result
sequenc
analys
three
experi
detect
sequenc
genet
fragment
respect
tabl
sequenc
conserv
element
underw
blast
analysi
highest
score
match
determin
ident
antibiot
resist
abr
element
predict
like
resist
associ
antibiot
final
pathogen
gene
repres
variou
toxin
virul
factor
pathogen
gener
result
shown
tabl
indic
despit
presenc
background
nucleic
acid
human
origin
expect
organ
detect
also
test
dna
extract
normal
nasal
wash
csf
sputum
sampl
determin
hybrid
pattern
background
organ
detect
human
mitochondri
dna
nasal
wash
specif
organ
found
csf
sampl
identifi
bacillu
human
mitochondri
dna
sputum
complex
sampl
larg
bacteri
load
complex
due
normal
flora
test
antibiot
resist
profil
strain
enterococcu
faecium
use
microarray
compar
result
obtain
use
antibiogram
phenotyp
refer
method
antibiot
resist
profil
determin
antibiogram
confirm
result
microarray
tabl
furthermor
inclus
gene
array
tetm
vana
allow
identif
differ
resist
mechan
util
strain
addit
detect
antibiot
resist
caus
presenc
specif
abr
gene
resequenc
design
pathogen
microarray
also
identifi
drug
resist
caus
mutat
confer
antibiot
resist
exampl
pefloxacin
resist
staphylococcu
aureu
confer
mutat
parcgen
detect
mutat
portion
parc
gene
staphylococcu
haemolyticu
result
amino
acid
chang
subsequ
resist
pefloxacin
fig
anoth
set
experi
six
bacteri
strain
isol
differ
clinic
sampl
test
experi
strain
correctli
identifi
use
rrna
sequenc
housekeep
gene
rpob
gyrb
global
correspond
antibiot
resist
gene
point
mutat
detect
microarray
resist
phenotyp
determin
antibiogram
excel
inde
shown
tabl
resist
phenotyp
result
acquir
gene
point
mutat
identifi
success
microarray
includ
point
mutat
parc
gene
confer
fluoroquinolon
resist
haemolyticusstrain
resist
phenotyp
due
either
absenc
gene
sequenc
tile
array
rifampicin
resist
haemolyticu
strain
resist
mechan
like
caus
overexpress
efflux
pump
microarray
approach
allow
us
identifi
antibiot
resist
gene
confer
spectinomycin
resist
test
routin
antibiogram
result
obtain
confirm
abil
microarray
detect
acquir
gene
accur
well
point
mutat
correspond
sequenc
tile
microarray
limit
approach
howev
case
multipl
bacteria
present
may
possibl
associ
resist
gene
conclus
respect
organ
wound
sampl
analys
microarray
eukaryot
bacteri
dna
extract
amplifi
via
two
success
ultra
fast
amplif
wga
reaction
aureu
dna
respons
wound
infect
repres
total
dna
extract
blast
analysi
sequenc
obtain
hybrid
array
reveal
presenc
aureu
one
member
bacteri
class
betaproteobacteria
known
commens
organ
wound
sampl
blast
analysi
also
identifi
four
antibiot
resist
gene
blaz
ermc
mph
tetk
antibiogram
result
confirm
aureu
strain
resist
penicillin
consist
presenc
blaz
detect
tetk
ermc
mph
gene
like
deriv
commens
organ
rather
aureu
molecular
techniqu
design
provid
posit
neg
result
specif
pathogen
test
may
design
detect
distinguish
close
relat
organ
approach
pathogen
array
tile
probe
four
nucleotid
posit
make
possibl
detect
point
mutat
sampl
rel
refer
sequenc
featur
greatli
expand
repertoir
identifi
organ
far
beyond
actual
includ
array
exampl
smallpox
viru
member
poxvirida
famili
compris
among
other
close
relat
monkeypox
camelpox
vaccinia
virus
smallpox
devast
diseas
share
sever
key
symptom
monkeypox
eg
format
skin
pustul
smallpox
declar
erad
world
health
organ
smallpox
viru
could
use
bioterror
threat
case
would
import
rapidli
distinguish
organ
close
rel
monkeypox
viru
caus
far
less
seriou
diseas
test
abil
array
distinguish
close
relat
pathogen
clinic
sampl
select
materi
african
child
suffer
pustular
infect
unknown
aetiolog
monkeypox
viru
suspect
damon
et
al
dna
extract
skin
sampl
amplifi
use
wga
gener
random
hexam
result
target
hybrid
microarray
nucleotid
sequenc
determin
signal
describ
cutler
et
al
compar
sequenc
genbank
result
portion
rna
polymeras
gene
shown
fig
sequenc
analysi
clinic
sampl
comparison
genbank
sequenc
variou
orthopoxvirus
reveal
sever
snp
clearli
distinguish
agent
detect
clinic
sampl
smallpox
viru
confirm
ident
monkeypox
viru
fig
expect
analysi
sequenc
obtain
array
reveal
sampl
also
contain
human
dna
evidenc
ribosom
rna
gene
human
mitochondri
sequenc
sequenc
analysi
also
reveal
presenc
aureu
normal
skin
commens
organ
see
appendix
supplementari
materialfor
detail
detail
sequenc
analysi
pathogen
profil
aureu
sequenc
determin
microarray
reveal
seven
gene
potenti
confer
resist
antibiot
blaz
macrolid
ermc
aminoglycosid
aph
aph
chloramphenicol
tetracyclin
tetk
tetm
famili
quinolon
methicillin
resist
gene
simultan
detect
monkeypox
viru
aureu
clinic
sampl
hamper
vast
excess
human
dna
aureu
bacteria
detect
sampl
antibiot
resist
gene
identifi
presum
deriv
aureu
confirm
monkeypox
result
qpcr
method
often
use
refer
laboratori
detect
pathogen
clinic
specimen
use
specif
primer
fragment
haemagglutinin
gene
amplifi
pcr
presenc
snp
distinguish
particular
orthopoxvirus
infer
melt
curv
peak
use
known
quantiti
plasmid
dna
gener
standard
curv
viral
load
scab
determin
genom
copi
per
microlitr
result
estim
total
dna
extract
clinic
sampl
viral
origin
gener
approach
allow
identif
suspect
agent
clinic
set
uncov
strain
aureu
follow
strictli
approach
monkeypox
viru
would
detect
howev
aureu
would
like
gone
unnot
perform
titrat
experi
known
quantiti
aureu
without
vast
excess
human
genom
dna
determin
limit
detect
use
current
assay
algorithm
result
shown
appendix
supplementari
materi
presenc
mass
excess
human
dna
detect
littl
genom
copi
aureu
absenc
human
dna
background
detect
littl
singl
genom
copi
aureu
certain
condit
time
diagnosi
critic
molecular
techniqu
pathogen
identif
suffer
lack
parallel
need
test
suspect
pathogen
nevertheless
rapid
produc
result
matter
hour
although
microarray
experi
typic
requir
h
gener
result
set
determin
set
condit
would
allow
us
combin
high
parallel
microarray
analysi
speed
techniqu
invers
relationship
concentr
microarray
hybrid
time
well
establish
pcr
product
report
complex
genom
sampl
base
result
human
genom
dna
hybrid
microarray
kennedi
et
al
reason
hybrid
time
mixtur
pathogen
amen
short
hybrid
time
long
appropri
amount
target
hybrid
therefor
test
effect
hybrid
time
sampl
contain
aureu
found
hybrid
time
short
min
provid
suffici
signal
identifi
genu
speci
organ
hybrid
time
littl
h
unambigu
identifi
antibiot
resist
spectrum
see
appendix
supplementari
materialfor
detail
organ
higher
gc
content
vibrio
vulnificu
requir
longer
hybrid
time
due
higher
background
effect
improv
partial
increas
amount
target
hybrid
array
data
shown
molecular
diagnost
approach
afford
number
advantag
tradit
phenotyp
method
recent
begun
find
applic
clinic
set
quantit
pcr
requir
design
optim
primer
pair
amplif
detect
knowledg
suspect
pathogen
therefor
requir
guid
test
clinic
sampl
inform
obtain
qpcr
restrict
presenc
absenc
pathogen
test
addit
inform
obtain
contrast
oligonucleotid
microarray
allow
determin
nucleotid
sequenc
accuraci
base
pair
dna
sequenc
inform
singl
experi
cutler
et
al
microarray
contain
sequenc
repres
gene
includ
conserv
gene
pathogen
virul
gene
antibiot
resist
gene
furthermor
abil
determin
nucleotid
sequenc
resolut
allow
potenti
identif
pathogen
similar
ident
sequenc
repres
microarray
exampl
although
pathogen
staphylococcu
epidermidi
repres
array
identifi
sampl
resequenc
portion
rrna
gene
aureu
data
shown
exemplifi
result
scab
sampl
identif
monkeypox
viru
includ
array
possibl
snp
detect
smallpox
viru
present
addit
potenti
use
identifi
known
pathogen
clinic
set
array
could
theoret
use
discov
new
organ
variant
thu
singl
applic
sampl
microarray
potenti
replac
thousand
individu
pcr
reaction
similarli
highli
multiplex
assay
replac
hundr
test
clinic
microbiologist
perspect
surviv
virul
gene
much
part
ident
pathogen
genu
speci
henc
import
look
beyond
conserv
gene
determin
speci
examin
antibiot
resist
profil
inform
treatment
decis
result
demonstr
abil
detect
larg
number
genet
element
even
within
complex
mixtur
presenc
larg
amount
human
dna
present
pathogen
identif
method
describ
limit
sequenc
deposit
ncbi
sequenc
databas
increas
avail
sequenc
data
new
organ
databas
improv
identif
organ
clinic
sampl
facilit
test
success
identifi
mani
pathogen
array
individu
see
appendix
supplementari
materi
howev
import
featur
unbias
pathogen
detect
clinic
set
abil
identifi
organ
mixtur
creat
mixtur
pathogen
show
array
capabl
deconvolut
correctli
identifi
organ
addit
mock
clinic
specimen
scab
sampl
illustr
abil
detect
bacteria
associ
abr
gene
viral
dna
test
detect
influenc
excess
human
dna
sampl
demonstr
discriminatori
power
tool
strength
pathogen
detect
complex
environ
test
sampl
differ
mock
syndrom
demonstr
abil
new
diagnost
tool
distinguish
two
virus
three
bacteria
even
organ
phylogenet
close
moreov
abil
perform
blast
analysi
sequenc
obtain
allow
us
identifi
pathogen
confid
elimin
risk
detect
pathogen
could
detect
classic
method
compar
mani
protocol
dna
microarray
use
overnight
hybrid
qpcr
allow
extrem
rapid
pathogen
identif
h
optim
microarray
assay
data
shown
allow
posit
identif
h
hybrid
time
signific
reduct
overal
assay
time
h
therefor
possibl
carri
pathogen
identif
use
techniqu
cours
singl
day
less
microarray
potenti
replac
thousand
individu
pcr
reaction
translat
major
reduct
cumul
assay
time
moreov
speed
assay
signific
improv
method
take
day
week
produc
result
technolog
describ
potenti
futur
util
clinic
set
exploratori
chip
use
studi
contain
million
probe
deliber
design
genet
inform
iter
may
involv
select
probe
convey
highest
discriminatori
valu
identifi
pathogen
envis
futur
array
contain
smaller
subset
probe
therefor
smaller
size
consequ
econom
addit
requir
clinic
util
protocol
describ
becom
streamlin
standard
autom
provid
time
result
within
hour
routin
set
current
perform
much
analysi
hand
softwar
develop
simplifi
interpret
result
although
dna
microarray
method
current
permit
identif
rapidli
qpcr
singl
pathogen
nonetheless
offer
advantag
gener
comprehens
detect
profil
aetiolog
agent
present
specimen
predict
antibiot
resist
therebi
enabl
suitabl
treatment
implement
promptli
seriou
outbreak
occur
rapid
effect
respons
could
initi
base
data
provid
microarray
therebi
facilit
appropri
patient
treatment
limit
propag
pathogen
descript
experiment
procedur
resid
appendix
supplementari
materi
